Immunotherapy News and Research

Latest Immunotherapy News and Research

Individualized therapies targeting specific features show promise in transforming cancer treatment

Individualized therapies targeting specific features show promise in transforming cancer treatment

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

Immune checkpoint inhibition may be effective in treating HIV-associated Kaposi's sarcoma

New article shines light on shared decision-making between allergists and patients

New article shines light on shared decision-making between allergists and patients

Researchers test experimental cancer vaccine on mice with aggressive melanoma

Researchers test experimental cancer vaccine on mice with aggressive melanoma

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Mayo Clinic physicians win SU2C Catalyst Award to fund melanoma research

Research uncovers how the immune system detects DNA damage

Research uncovers how the immune system detects DNA damage

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

Phase 2 clinical study reports best outcomes to date for older Hodgkin lymphoma patients

New study reports key steps towards development of acne vaccine

New study reports key steps towards development of acne vaccine

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Researchers discover reason why many bladder cancer patients do not respond to immunotherapy

Researchers identify neutrophil progenitor in the bone marrow of mice and humans

Researchers identify neutrophil progenitor in the bone marrow of mice and humans

A non-canonical approach may improve radiation treatment for cancer

A non-canonical approach may improve radiation treatment for cancer

New combination treatment could help some people with advanced melanoma

New combination treatment could help some people with advanced melanoma

New personalized cellular therapy approved for use in the European Union

New personalized cellular therapy approved for use in the European Union

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

New radiomic signature offers predictive score for efficacy of immunotherapy in patients

MSU researchers move one step closer to solving arthritic disease in teenagers

MSU researchers move one step closer to solving arthritic disease in teenagers

New treatment destroys part of tumor and attacks persistent surviving cancer cells

New treatment destroys part of tumor and attacks persistent surviving cancer cells

Researchers work to create humanized mouse model to test immunotherapies

Researchers work to create humanized mouse model to test immunotherapies

Bluebird bio collaborates with Gritstone Oncology to develop novel cancer cell therapies

Bluebird bio collaborates with Gritstone Oncology to develop novel cancer cell therapies

Immunotherapy combination shrinks melanoma that has spread to the brain

Immunotherapy combination shrinks melanoma that has spread to the brain

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.